Pharmagest Interactive SA
F:PHF
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
44.55
65.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PHF stock under the Base Case scenario is 72.1 EUR. Compared to the current market price of 45 EUR, Pharmagest Interactive SA is Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Pharmagest Interactive SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PHF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Pharmagest Interactive SA
Balance Sheet Decomposition
Pharmagest Interactive SA
Current Assets | 132.3m |
Cash & Short-Term Investments | 54.7m |
Receivables | 67.3m |
Other Current Assets | 10.3m |
Non-Current Assets | 261.8m |
Long-Term Investments | 95.1m |
PP&E | 32.9m |
Intangibles | 130.3m |
Other Non-Current Assets | 3.5m |
Current Liabilities | 108.1m |
Accounts Payable | 16.1m |
Other Current Liabilities | 92m |
Non-Current Liabilities | 66.6m |
Long-Term Debt | 44.7m |
Other Non-Current Liabilities | 22m |
Earnings Waterfall
Pharmagest Interactive SA
Revenue
|
219.8m
EUR
|
Cost of Revenue
|
-69.1m
EUR
|
Gross Profit
|
150.6m
EUR
|
Operating Expenses
|
-95.4m
EUR
|
Operating Income
|
55.2m
EUR
|
Other Expenses
|
-8.2m
EUR
|
Net Income
|
47m
EUR
|
Free Cash Flow Analysis
Pharmagest Interactive SA
EUR | |
Free Cash Flow | EUR |
PHF Profitability Score
Profitability Due Diligence
Pharmagest Interactive SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Pharmagest Interactive SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
PHF Solvency Score
Solvency Due Diligence
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHF Price Targets Summary
Pharmagest Interactive SA
According to Wall Street analysts, the average 1-year price target for PHF is 83.12 EUR with a low forecast of 63.43 EUR and a high forecast of 107.69 EUR.
Dividends
Current shareholder yield for PHF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PHF Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one PHF stock under the Base Case scenario is 72.1 EUR.
Compared to the current market price of 45 EUR, Pharmagest Interactive SA is Undervalued by 38%.